ArticleVirus research2023

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes.

Yuki Takamatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.